Answers are grounded in this paper and cite their sources.
With the introduction of specific or unspecific biomarkers, the diagnosis of dementia disorders has changed from a purely clinical to a biological construct. This review presents biomarkers for the most common neurodegenerative disorders. Specific biomarkers for misfolded proteins have been developed for Alzheimer's disease and dementia with Lewy bodies. Unspecific biomarkers for neurodegeneration, synaptic dysfunction and neuroinflammation may also be helpful in diagnosing or staging dementia disorders.
No takes yet. Share an insight, caveat, or question.
Steen Gregers Hasselbalch (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: